3,4-dihydroxyethylamphetamine

Known as: (OH)2-Et-amphetamine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2012

2012

Investigations on the stereoselectivity of the phase II metabolism of the 3,4-methylenedioxyethylamphetamine (MDEA) metabolites 3,4-dihydroxyethylamphetamine (DHEA) and 4-hydroxy-3…

Andrea Eva Schwaninger, Markus R Meyer, Josef Zapp, Hans H Maurer
Toxicology letters
2012

Different elimination was reported for the two enantiomers of the designer drug 3,4-methylenedioxyethylamphetamine (MDEA) in vivo… (More)

Is this relevant?

1996

1996

Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.

H. K. Ensslin, Hans H Maurer, Euphrosyne Gouzoulis, Leopold Hermle, Karl Artur Kovar
Drug metabolism and disposition: the biological…
1996

Studies on the isolation, identification, quantification, and synthesis of the urinary metabolites of racemic 3,4… (More)

Is this relevant?